
Darshan Lal Arora
About Darshan Lal Arora
Data last updated:
Darshan Lal Arora is a Director at Maksun Biotech Private Limited (since 2013) and Director at Blair Remedies Private Limited (since 2016). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹24.22 Cr; the largest is Maksun Biotech Private Limited at ₹16.99 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Nov 2013 | 2013 | ₹16.99 Cr (FY 2025) | Active | |
| Director | 16 Mar 2016 | 2016 | ₹7.23 Cr (FY 2025) | Active |
Board colleagues of Darshan Lal Arora
| Name | DIN | Company | Designation |
|---|---|---|---|
| Himanshu | 06664879 | Maksun Biotech Private Limited | Director |
| Ruchir Kumar | 06663435 | Maksun Biotech Private Limited | Director |
| Kashish Dawra | 07456729 | Blair Remedies Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Darshan Lal Arora
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Darshan Lal Arora
Darshan Lal Arora currently holds 2 directorships: Maksun Biotech Private Limited (Director, since 04 Nov 2013, revenue ₹16.99 Cr (FY 2025)); Blair Remedies Private Limited (Director, since 16 Mar 2016, revenue ₹7.23 Cr (FY 2025)).
Darshan Lal Arora was first appointed on 04 Nov 2013 as Director at Maksun Biotech Private Limited. The most recent appointment on record is 16 Mar 2016 at Blair Remedies Private Limited.
The 2 current companies of Darshan Lal Arora that report revenue have a combined latest revenue of ₹24.22 Cr: Maksun Biotech Private Limited ₹16.99 Cr (FY 2025); Blair Remedies Private Limited ₹7.23 Cr (FY 2025).
The current boards of Darshan Lal Arora's companies include Himanshu (Maksun Biotech Private Limited), Ruchir Kumar (Maksun Biotech Private Limited), Kashish Dawra (Blair Remedies Private Limited).